Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Rocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.

This is what you need to keep in the back of your mind as you compare Kraft Heinz (NASDAQ: KHC) to Coca-Cola (NYSE: KO). Both ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...